- জেনেরিক নাম
- Bivalirudin
- শক্তি
- 250 mg/5 ml
- ডোজ ফর্ম
- IV Injection
- প্রস্তুতকারক
- Healthcare Pharmaceuticals Ltd.
- থেরাপিউটিক ক্লাস
- Anti-platelet drugs
৳ ৯৮০০ ৳ ১০০০০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Biva 250 mg/5 ml IV Injection একটি IV Injection ঔষধ, যার জেনেরিক নাম Bivalirudin এবং শক্তি ২৫০ mg/৫ ml। ঔষধটি Anti-platelet drugs শ্রেণির অন্তর্ভুক্ত। দাম: প্রতি ইউনিট ১০০০০.০০ টাকা। Bivalirudin-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Healthcare Pharmaceuticals Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Biva 250 mg/5 ml iv injection is a medicine made by Healthcare Pharmaceuticals Ltd. Bivalirudin is indicated for: Anticoagulant in Patients Undergoing PTCA/PCI or PCI with HITS/HITTS Unstable Angina/Non-ST-Elevation MI (Off-label) STEMI Undergoing Primary PCI (Off-label) Heparin-induced Thrombocytopenia The clinical relevance of these findings is unknown. Ask your doctor or pharmacist if you are unsure about it.
Bivalirudin is indicated for: Anticoagulant in Patients Undergoing PTCA/PCI or PCI with HITS/HITTS Unstable Angina/Non-ST-Elevation MI (Off-label) STEMI Undergoing Primary PCI (Off-label) Heparin-induced Thrombocytopenia Ask your doctor whether it is right for your condition.
Biva is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Take Biva 250 mg/5 ml iv injection exactly as your doctor prescribes. Complete the course exactly as prescribed. If you miss a dose, ask your doctor or pharmacist what to do.
Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Nursing Mothers : It is not known whether Bivalirudin is excreted in human milk. Coronary Artery Brachy therapy : An increased risk of thrombus formation, including fatal outcomes, has been associated with the use of Bivalirudin in gamma brachytherapy. No adequate and well-controlled studies in pregnant women. Ask your doctor first if any of these apply to you.
Bivalirudin is indicated for: Anticoagulant in Patients Undergoing PTCA/PCI or PCI with HITS/HITTS Unstable Angina/Non-ST-Elevation MI (Off-label) STEMI Undergoing Primary PCI (Off-label) Heparin-induced Thrombocytopenia Ask your doctor whether it is right for your condition.
Biva is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how.
Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
The listed price is ৳ ১০০০০.০০.
৳ ৯৮০০ ৳ ১০০০০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Bivalirudin is indicated for:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Bivalirudin directly inhibits thrombin by specifically binding both to the catalytic site and to the anion-binding exosite of circulating and clot-bound thrombin. Thrombin is a serine proteinase that plays a central role in the thrombotic process, acting to cleave fibrinogen into fibrin monomers and to activate Factor XIII to Factor XIIIa, allowing fibrin to develop a covalently cross-linked framework which stabilizes the thrombus; thrombin also activates Factors V and VIII, promoting further thrombin generation, and activates platelets, stimulating aggregation and granule release. The binding of bivalirudin to thrombin is reversible as thrombin slowly cleaves the bivalirudin-Arg3-Pro4 bond, resulting in recovery of thrombin active site functions.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
PCI/PTCA: IV Bolus dose of 0.75 mg/kg followed by an infusion of 1.75 mg/kg/h for duration of PCI procedure. Five minutes after bolus dose, obtain ACT and administer additional bolus of 0.3 mg/kg if indicated.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Co-administration of Bivalirudin with heparin, warfarin, thrombolytics, or GPIs was associated with increased risks of major bleeding events.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Bivalirudin is contraindicated in patients with: Active majorএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category B. No adequate and well-controlled studies in pregnant women. As animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Bivalirudin is intended for use with aspirin . Because of possible adverse effects on the neonate and the potential for increased maternal bleeding, particularly during the third trimester, Bivalirudin and aspirin should be used together during pregnancy only if clearly needed.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Bleeding Events: Although most bleeding associated with the use of Bivalirudin in PCI/PTCA occurs at the site of arterial puncture, hemorrhage can occur at any site. An unexplained fall in blood pressure or hematocrit should lead to serious consideration of a hemorrhagic event and cessation of Bivalirudin administration. Bivalirudin should be used with caution in patients with disease states associated with an increased risk of bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Cases of overdose of up to 10 times the recommended bolus or continuous infusion dose of Bivalirudin have been reported in clinical trials and in postmarketing reports. A number of the reported overdoses were due to failure to adjust the infusion dose of bivalirudin in persons with renal dysfunction including persons on hemodialysis . Bleeding, as well as deaths due to hemorrhage, have been observed in some reports of overdose. In cases of suspected overdosage, discontinue Bivalirudin immediately and monitor the patient closely for signs of bleeding. There is no known antidote to Bivalirudin. Bivalirudin is hemodialyzableএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store at temperature not exceeding 30º C in a dry place. Do not freeze. Keep out of reach of childrenঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।